242 related articles for article (PubMed ID: 22080762)
1. The relative amounts of plasma transthyretin forms in familial transthyretin amyloidosis: a quantitative analysis by Fourier transform ion-cyclotron resonance mass spectrometry.
Ribeiro-Silva C; Gilberto S; Gomes RA; Mateus É; Monteiro E; Barroso E; Coelho AV; da Costa G; Freire AP; Cordeiro C
Amyloid; 2011 Dec; 18(4):191-9. PubMed ID: 22080762
[TBL] [Abstract][Full Text] [Related]
2. α-Synuclein aggregation in the saliva of familial transthyretin amyloidosis: a potential biomarker.
Guerreiro A; da Costa G; Gomes RA; Ribeiro-Silva C; Gilberto S; Mateus E; Monteiro E; Barroso E; Coelho AV; Ponces Freire A; Cordeiro C
Amyloid; 2012 Jun; 19(2):74-80. PubMed ID: 22591216
[TBL] [Abstract][Full Text] [Related]
3. Identification of S-sulfonation and S-thiolation of a novel transthyretin Phe33Cys variant from a patient diagnosed with familial transthyretin amyloidosis.
Lim A; Prokaeva T; McComb ME; Connors LH; Skinner M; Costello CE
Protein Sci; 2003 Aug; 12(8):1775-85. PubMed ID: 12876326
[TBL] [Abstract][Full Text] [Related]
4. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T
J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367
[TBL] [Abstract][Full Text] [Related]
5. Proportion between wild-type and mutant protein in truncated compared to full-length ATTR: an analysis on transplanted transthyretin T60A amyloidosis patients.
Ihse E; Stangou AJ; Heaton ND; O'Grady J; Ybo A; Hellman U; Edvinsson A; Westermark P
Biochem Biophys Res Commun; 2009 Feb; 379(4):846-50. PubMed ID: 19118530
[TBL] [Abstract][Full Text] [Related]
6. Presence of variant transthyretin in aqueous humor of a patient with familial amyloidotic polyneuropathy after liver transplantation.
Haraoka K; Ando Y; Ando E; Sun X; Nakamura M; Terazaki H; Misumi S; Tanoue Y; Tajiri T; Shoji S; Ishizaki T; Okabe H; Tanihara H
Amyloid; 2002 Dec; 9(4):247-51. PubMed ID: 12557753
[TBL] [Abstract][Full Text] [Related]
7. Identification and quantitative analysis of human transthyretin variants in human serum by Fourier transform ion-cyclotron resonance mass spectrometry.
da Costa G; Gomes R; Correia CF; Freire A; Monteiro E; Martins A; Barroso E; Coelho AV; Outeiro TF; Ponces Freire A; Cordeiro C
Amyloid; 2009 Dec; 16(4):201-7. PubMed ID: 19922331
[TBL] [Abstract][Full Text] [Related]
8. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
[TBL] [Abstract][Full Text] [Related]
9. Marked biochemical difference in amyloid proportion between intra- and extraocular tissues in a liver-transplanted patient with hereditary ATTR amyloidosis.
Yoshinaga T; Yazaki M; Kametani F; Sekijima Y; Iesato Y; Miyahara T; Tsuchiya-Suzuki A; Sano K; Higuchi K; Ikeda SI
Amyloid; 2017 Mar; 24(1):17-23. PubMed ID: 28081655
[TBL] [Abstract][Full Text] [Related]
10. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
Sekijima Y
J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
[TBL] [Abstract][Full Text] [Related]
11. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.
Yamashita T; Ueda M; Misumi Y; Masuda T; Nomura T; Tasaki M; Takamatsu K; Sasada K; Obayashi K; Matsui H; Ando Y
J Neurol; 2018 Jan; 265(1):134-140. PubMed ID: 29177547
[TBL] [Abstract][Full Text] [Related]
12. Presence of N-glycosylated transthyretin in plasma of V30M carriers in familial amyloidotic polyneuropathy: an escape from ERAD.
Teixeira AC; Saraiva MJ
J Cell Mol Med; 2013 Mar; 17(3):429-35. PubMed ID: 23387326
[TBL] [Abstract][Full Text] [Related]
13. Analysis of transthyretin in human serum by capillary zone electrophoresis electrospray ionization time-of-flight mass spectrometry. Application to familial amyloidotic polyneuropathy type I.
Pont L; Benavente F; Barbosa J; Sanz-Nebot V
Electrophoresis; 2015 Jun; 36(11-12):1265-73. PubMed ID: 25820240
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel transthyretin Thr59Lys/Arg104His. A case of compound heterozygosity in a Chinese patient diagnosed with familial transthyretin amyloidosis.
Lim A; Prokaeva T; Connor LH; Falk RH; Skinner M; Costello CE
Amyloid; 2002 Jun; 9(2):134-40. PubMed ID: 12440486
[TBL] [Abstract][Full Text] [Related]
15. Biochemical characteristics of variant transthyretins causing hereditary leptomeningeal amyloidosis.
Mitsuhashi S; Yazaki M; Tokuda T; Sekijima Y; Washimi Y; Shimizu Y; Ando Y; Benson MD; Ikeda S
Amyloid; 2005 Dec; 12(4):216-25. PubMed ID: 16399646
[TBL] [Abstract][Full Text] [Related]
16. Impact of antibodies against amyloidogenic transthyretin (ATTR) on phenotypes of patients with familial amyloidotic polyneuropathy (FAP) ATTR Valine30Methionine.
Obayashi K; Tasaki M; Jono H; Ueda M; Shinriki S; Misumi Y; Yamashita T; Oshima T; Nakamura T; Ikemizu S; Anan I; Suhr O; Ando Y
Clin Chim Acta; 2013 Apr; 419():127-31. PubMed ID: 23462670
[TBL] [Abstract][Full Text] [Related]
17. Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M).
Lobato L
J Nephrol; 2003; 16(3):438-42. PubMed ID: 12832749
[TBL] [Abstract][Full Text] [Related]
18. Characterization of transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping and DNA sequence analysis.
Lim A; Prokaeva T; McComb ME; O'Connor PB; Théberge R; Connors LH; Skinner M; Costello CE
Anal Chem; 2002 Feb; 74(4):741-51. PubMed ID: 11866053
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation and anemia in familial amyloidosis ATTR V30M.
Beirão I; Lobato L; Costa PM; Fonseca I; Silva M; Bravo F; Cabrita A; Porto G
Amyloid; 2007 Mar; 14(1):33-7. PubMed ID: 17453623
[TBL] [Abstract][Full Text] [Related]
20. Cys-10 mixed disulfide modifications exacerbate transthyretin familial variant amyloidogenicity: a likely explanation for variable clinical expression of amyloidosis and the lack of pathology in C10S/V30M transgenic mice?
Zhang Q; Kelly JW
Biochemistry; 2005 Jun; 44(25):9079-85. PubMed ID: 15966731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
